Ketoconazole + Chlorhexidine + Acetic Acid

Verify with FDA CVM →

18 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
18
Total Reports
1
Deaths Reported
560.0%
Death Rate

Active Ingredients

Ketoconazole + Chlorhexidine + Acetic Acid

Administration Routes

Auricular (Otic)TopicalUnknownCutaneous

Species Affected

Dog 13
Cat 5

Most Affected Breeds

Retriever - Labrador 4
Domestic Shorthair 4
Shih Tzu 2
Pit Bull 1
Pug 1
Bulldog - American 1
Terrier (unspecified) 1
Terrier - Yorkshire 1
Bengal 1
Dachshund (unspecified) 1

Most Reported Reactions

Lack of efficacy - NOS 6
Vomiting 3
Emesis 2
Itching 2
Ear pain 2
Loss of hearing 2
Reddening of the skin 1
UNPALATABLE 1
Ear discharge 1
Otitis media 1
Ear irritation 1
CULTURE/TITER DATA ABNORMAL 1

Outcome Breakdown

Ongoing
8 (44.4%)
Outcome Unknown
5 (27.8%)
Recovered/Normal
3 (16.7%)
Euthanized
1 (5.6%)
Recovered with Sequela
1 (5.6%)

Data Summary

Metric Value
Total adverse event reports 18
Reports involving death 1
Case-fatality rate (reported events) 560.0%
Distinct species in reports 2
Distinct breeds in reports 11
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ketoconazole + Chlorhexidine + Acetic Acid Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 18 adverse event reports referencing Ketoconazole + Chlorhexidine + Acetic Acid, including 1 reports in which the animal died — a 560.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ketoconazole + Chlorhexidine + Acetic Acid. Reported administration routes include Auricular (Otic), Topical, Unknown, Cutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ketoconazole + Chlorhexidine + Acetic Acid reports are Dog (13 reports), Cat (5 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (4), Domestic Shorthair (4), Shih Tzu (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ketoconazole + Chlorhexidine + Acetic Acid are Lack of efficacy - NOS (6), Vomiting (3), Emesis (2), Itching (2). Of the 18 reports with a coded outcome, Ongoing is the leading category at 44.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ketoconazole + Chlorhexidine + Acetic Acid.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial